91Ë¿¹ÏÊÓÆµ

Event Program

Wednesday, November 25

Ìý

  • 12:00 PM – 01:00 PM: REGISTRATION AND COFFEE
  • 01:00 PM – 01:15 PM: OPENING REMARKS
  • 01:15 PM – 02:50 PM: PANEL DISCUSSION 1 - INNOVATIVE APPROACHES USING RNA TECHNOLOGIES

Chair:
TBD

Talk 1:Ìý
Philippe Gros, PhD.ÌýÌýChief Scientific Officer at 91Ë¿¹ÏÊÓÆµ's DNA toÌýRNA (D2R) Program; Professor at the Department of Biochemistry, Human Genetics, 91Ë¿¹ÏÊÓÆµ.

Talk 2:Ìý
Martin Sauvageau, PhD,ÌýScientific Director of RNA Therapeutics Platform at Institut de recherches cliniques de Montréal (IRCM); Assistant Professor at the Department of Biochemistry and Molecular Medicine, Université de Montréal

Talk 3:
TBD

Discussion and Q&A

  • 02:50 PM – 03:15ÌýPM: COFFEE BREAK
  • 03:15 PM – 03:25 PM: INDUSTRY SPOTLIGHT PRESENTATIONS
  • 03:25 PM – 05:00 PM: PANEL DISCUSSION 2 - THERAPEUTICS & OMICS

Chair: Sylvie Mader, PhD,ÌýÌýScientific Co-Director at Chemogenix Core Facility; Professor at the Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Université de Montréal

Talk 1:
AlexandreÌýLe Bouthillier, PhD.  ChiefÌýExecutive Officer at Linearis

Talk 2:
Anne Marinier,ÌýPhD. Ìý
Chief ExecutiveÌýOfficer atÌýRejuvenRXÌýandÌýProfessorÌýat the Department of pharmacology and physiology, Université de MontréalÌý

Talk 3:
Isabelle Sirois,ÌýPhD.ÌýResearcher and Head of the Pediatric Proteomics andÌýImmunopeptidomicsÌýPlatformÌýat ÌýCHUSJÌý

Talk 4 (Trainee Presentation):Ìý
TBD

Discussion and Q&A

  • 05:00 PM –07:00 PM: NETWORKING COCKTAIL AND POSTER EXHIBITION

Ìý

Thursday, November 26

  • 08:30 AM – 09:00 AM: REGISTRATION AND COFFEE
  • 09:00 AM – 09:30 AM: PATIENT VOICE

Chair: TBD

Talk:ÌýÌý
Catherine Wilhelmi,ÌýCo-Director (Scientific Leadership), Quebec SPOR Support Unit; Patient Partnership Coordinator, CHUS Research Centre

Q&A

  • 09:30 AM – 09:40 AM:ÌýINDUSTRY SPOTLIGHT PRESENTATIONS
  • 09:40 AM – 10:00 AM: COFFEE BREAK
  • 10:00 AM – 11:25ÌýAM: PANEL DISCUSSION 3 -ÌýADVANCING DISCOVERIES TO THE CLINIC

Chair: Valérie Thibodeau, PhD, Executive Director at MCTRC

Talk 1:
Sarit Assouline, MD.  Associate Director of Clinical Research Unit at Jewish General Hospital; Associate Professor at Departments of Medicine and Oncology, 91Ë¿¹ÏÊÓÆµ

Talk 2:
Catherine Beauchemin, Ph.D. Partner at PeriPharm; Associate Professor at the Faculty of Pharmacy, Université de Montréal

Talk 3:
Nadia Chanane,
Regional Director at Axelys

Discussion and Q&A

  • 11:25 AM – 12:15 PM: POSTER EXHIBITION AND EVALUATIONÌý
  • 12:15 PM – 01:15 PM: LUNCH BREAK
  • 01:15 PM – 02:50 PM: PANEL DISCUSSION 4 -ÌýLIQUID BIOPSY AND NOVEL DIAGNOSTIC TECHNOLOGIES

Chair: Adriana Aguliar, PhD, Scientific Director of the Cancer Genomics and Translational Research Laboratory

Talk 1:
Rodney Ouellette, MD. PhD.  Scientific Director, Atlantic Cancer Research Institute

Talk 2:
Madline Sauvage, PhD.  Chief Executive Officer at SensEn; Executive Vice President at OneCare Biotechnologies

Talk 3:
Vincent Lavallée, MD, PhD, Scientific Director at Integrated Genomics Meta-Platform; Associate Professor at the Department of Pediatrics, Université de MontréalTalk 4 (Trainee Presentation):

Discussion and Q&A

  • 02:50 PM – 03:00 PM:ÌýINDUSTRY SPOTLIGHT PRESENTATIONS
  • 03:00 PM – 03:30 PM: COFFEE BREAK
  • 03:30 PM – 05:05 PM: PANEL DISCUSSION 5 - MULTIMODAL DATA & MISSING MODALITIES

TBD

Chair: TBD

Talk 1:
Morteza Rezanejad, PhD. Assistant Professor at the Electrical and Computer Engineering Department, Concordia University

Talk 2:
John Kildea, PhD.  Associate Professor at the Department of Oncology, 91Ë¿¹ÏÊÓÆµ

Talk 3:
Martin Vallières, PhD.  Associate Professor at the School of Computer Science, 91Ë¿¹ÏÊÓÆµ

Talk 4 (Trainee Presentation):
TBD

Discussion and Q&A

  • 05:05 PM – 05:30 PM: AWARD CEREMONY & CLOSING REMARKS

Ìý

Back to top